SCHEMBL22258464

SCHEMBL22258464

C=C(Nc1c[nH]nc1C(=C)Nc1ccc(N2CCC(F)(F)C2)nc1)c1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.49
▸ CLK2 P49760 5/20 0.49
▸ CLK3 P49761 3/20 0.41
▸ CRBN Q96SW2 1/20 0.34
▸ CACNA1H O95180 6/20 0.33
▸ WNT1 P04628 2/20 0.33
▸ KLKB1 P03952 1/20 0.33
▸ KLK1 P06870 1/20 0.33
▸ CRACR2A Q9BSW2 1/20 0.33
▸ DGAT1 O75907 1/20 0.33
▸ CYP2C19 P33261 1/20 0.32
▸ CACNA1G O43497 1/20 0.31
▸ CACNA1I Q9P0X4 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22258821 0.88 DYRK1A (0.48) DYRK1ACLK2CLK3CRBNCACNA1H
SCHEMBL22258449 0.87 DYRK1A (0.47) DYRK1ACLK2CLK3CRBNCACNA1H
SCHEMBL22258230 0.87 NPC1 (0.40) DYRK1ACLK2CLK3WNT1HDAC3
SCHEMBL22258478 0.86 NPC1 (0.41) DYRK1ACLK2CLK3WNT1HDAC1
SCHEMBL22258825 0.86 CLK2 (0.40) DYRK1ACLK2CLK3CRBNCACNA1H
SCHEMBL22235747 0.85 CLK2 (0.55) DYRK1ACLK2CLK3WNT1CRACR2A
SCHEMBL22258263 0.84 DYRK1A (0.65) DYRK1ACLK2CLK3CRBNCACNA1H
SCHEMBL22258536 0.81 DYRK1A (0.47) DYRK1ACLK2CLK3CACNA1HWNT1
SCHEMBL22258448 0.78 LMNA (0.46) DYRK1ACLK2CLK3
SCHEMBL22258452 0.77 CLK2 (0.43) DYRK1ACLK2CRACR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150545-A1 PYRAZOLE DERIVATIVES AS MODULATORS OF THE WNT/B-CATENIN SIGNALING PATHWAY SAMUMED, LLC (US) 2020-07-23 — — WO disclosed
Send feedback